Vaccine News and Research

Latest Vaccine News and Research

SARS-CoV-2 spike protein discovery could pave way for COVID-19 vaccine

Researchers at the Indian Institute of Technology, Guwahati, have made an important discovery about a viral fusion protein found on the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could help researchers develop a vaccine.

27 Apr 2020

Study can lead the way to new treatment methods for hepatitis C in infants

Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease.

27 Apr 2020

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

A new study reports the induction of high levels of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing the current pandemic of COVID-19. This promising finding was reported on the preprint server bioRxiv on April 2020.

26 Apr 2020

Is the BCG vaccine really protective against COVID-19?

A new paper published on the preprint server medRxiv in April 2020 challenges the hypothesis that BCG vaccination confers some degree of protection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the pneumonic illness COVID-19.

26 Apr 2020

Microclimate and turbulent wind can influence COVID-19 spread over long distances

Respiratory particles exhaled after a sneeze can be transported by the turbulent wind more than three times further than current social or physical distancing measures recommend, reports a new study from Chile available on the preprint server medRxiv.

26 Apr 2020

A new test for rapid large-scale testing of COVID-19

OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider

25 Apr 2020

UCLA scientists receive awards to pursue treatments and vaccines for COVID-19

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards to pursue treatments and vaccines for COVID-19 from the California Institute for Regenerative Medicine, the state's stem cell agency.

25 Apr 2020

Resurgence of measles or polio outbreaks likely to happen, experts warn

Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn.

24 Apr 2020

USask's VIDO-Intervac receives $23 million to fast-track development of COVID-19 vaccine

The University of Saskatchewan's VIDO-InterVac (Vaccine and Infectious Disease Organization-International Vaccine Centre) has been awarded $23 million to fast-track efforts to develop a COVID-19 vaccine, Prime Minister Justin Trudeau announced today.

24 Apr 2020

FAU scientists aim to develop a passive vaccine against COVID-19

Nothing less than the development of a passive vaccine against Covid-19 has been undertaken by a team of scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinkum Erlangen and their partners from the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig and the German Primate Centre in Göttingen.

24 Apr 2020

Anti-vaccine activists latch onto coronavirus to bolster their movement

While most of the world hungers for a vaccine to put an end to the death and economic destruction wrought by COVID-19, some anti-vaccine groups are joining with anti-lockdown protesters to challenge restrictions aimed at protecting public health.

24 Apr 2020

American Lung Association calls for urgent universal COVID-19 antibody testing

The COVID-19 pandemic has resulted in unprecedented rates of lung infections and deaths in modern history.

24 Apr 2020

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Before being halted due to the COVID-19 pandemic, a relentless vaccination campaign had nearly succeeded in eradicating polio from the world.

24 Apr 2020

Unprecedented effects of COVID-19 on digital health sector and future considerations

Dr Janak Gunatilleke, CEO at Mindwave Ventures, reflects on the effect COVID-19 is having on the UK NHS and what that means for digital health.

24 Apr 2020

Study highlights a new way to increase crop production

During the past few weeks, empty supermarket shelves, without pasta, rice and flour due to panic buying, has caused public concerns about the possibility of running out of food.

24 Apr 2020

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

NEC Corporation today announced analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell responses in the majority of the global population.

24 Apr 2020

Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials

The Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.

24 Apr 2020

UM researchers awarded $2.5 million to develop COVID-19 vaccine candidate

Researchers in the Center for Translational Medicine at the University of Montana have been awarded $2.5 million in funding from the National Institutes of Health to identify and advance a COVID-19 vaccine candidate.

24 Apr 2020

Sweden may reach ‘herd immunity’ in weeks as the country resists total lockdown

Herd immunity is a form of indirect protection against infectious diseases where a population develops sufficient immunity to a disease that that infection cannot spread within the group. A population can reach herd immunity if a large proportion has been exposed to the virus. Now, Sweden resisted total lockdown measures, unlike its neighboring countries, while experts believe herd immunity will be achieved in Stockholm within weeks.

24 Apr 2020

First COVID-19-related clinical trial to start in Germany

German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.

24 Apr 2020

Vaccine News and Research

Latest Vaccine News and Research

SARS-CoV-2 spike protein discovery could pave way for COVID-19 vaccine

Study can lead the way to new treatment methods for hepatitis C in infants

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

Is the BCG vaccine really protective against COVID-19?

Microclimate and turbulent wind can influence COVID-19 spread over long distances

A new test for rapid large-scale testing of COVID-19

UCLA scientists receive awards to pursue treatments and vaccines for COVID-19

Resurgence of measles or polio outbreaks likely to happen, experts warn

USask's VIDO-Intervac receives $23 million to fast-track development of COVID-19 vaccine

FAU scientists aim to develop a passive vaccine against COVID-19

Anti-vaccine activists latch onto coronavirus to bolster their movement

American Lung Association calls for urgent universal COVID-19 antibody testing

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Unprecedented effects of COVID-19 on digital health sector and future considerations

Study highlights a new way to increase crop production

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials

UM researchers awarded $2.5 million to develop COVID-19 vaccine candidate

Sweden may reach ‘herd immunity’ in weeks as the country resists total lockdown

First COVID-19-related clinical trial to start in Germany

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in